PTK2 and neoplasm: The flavone luteolin was reported to block EGFR tyrosine kinase activity, which resulted in the reduction in FAK expression also accompanied by lower FAK tyrosine phosphorylation levels, leading to cell invasion inhibition in MiaPaCa-2 and A431 tumor cell lines [173].